search
Back to results

SMYLS Multi-site Trial

Primary Purpose

Sickle Cell Disease

Status
Not yet recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Voice Crisis Alert V2
Electronic educational materials
Sponsored by
Medical University of South Carolina
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Sickle Cell Disease

Eligibility Criteria

14 Years - 21 Years (Child, Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: documentation in the electronic health record of any type of SCD owns mobile device compatible with the intervention access to the internet Exclusion Criteria: Plans to relocate outside of study site area in the next 12 months Plans to transition to adult care in 12 months or less Parent/caregiver or provider report of neurocognitive impairment that precludes ability to use intervention and participate in study non-English speaking

Sites / Locations

  • Medical University of South Carolina

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Intervention

Control

Arm Description

Study participants randomized to receive the intervention.

Study participants randomized to receive enhanced usual care (control).

Outcomes

Primary Outcome Measures

Self-management behaviors
Adolescent and young adult self-report using the Transition Readiness Assessment Questionnaire 5th version (TRAQ-5; 20 items). The instrument consists of 5 scales. Individual item scores range from 1 - 5. Scale scores are determined by calculating the average of the item scores within each scale. Higher scores indicate greater transition readiness and self-management behaviors.

Secondary Outcome Measures

Engagement in intervention/control (categorical)
Categorized into none, low, moderate and high. For intervention arm, categories are based on scope (number of components), duration (number of weeks), and frequency (number of times per week). For control arm, categories are based on duration and frequency as for intervention group parameters.
Engagement in intervention/control (continuous)
Number of times the application is accessed (intervention = full application; control = educational component only).
Health-related quality of life
Adolescent and young adult self report using the Pediatric Quality of Life Inventory (PedsQL) with Sickle Cell Disease Module (43 items). Items are scaled from 0 (Never) to 4 (Almost always). Scores are reverse scored and linearly transformed to a 0 - 100 scale. Higher scores indicate better health-related quality of life.
Number of attended SCD clinic visits
Number of attended SCD clinic visits documented in the medical record
Number of ED visits
Number of ED visits documented in the medical record
Number of hospitalizations
Number of hospitalizations documented in the medical record
Pain interference
Adolescent and young adult self report using the Patient Reported Outcomes Measurement Inventory System (PROMIS) Pain Interference v2 Pediatric Short Form (8 items). Raw scores range from 0 - 32 with higher scores indicating greater pain interference.
Transition readiness
Adolescent and young adult self report using the Transition Intervention Program - Readiness for Transition (TIP-RFT; 22 items). Scores for each item range from 0 - 4, with a total possible summed score ranging from 0 - 88. Lower scores indicate higher transition readiness.

Full Information

First Posted
August 29, 2023
Last Updated
September 6, 2023
Sponsor
Medical University of South Carolina
Collaborators
National Institute of Nursing Research (NINR)
search

1. Study Identification

Unique Protocol Identification Number
NCT06035939
Brief Title
SMYLS Multi-site Trial
Official Title
Self-Management for Youth Living With Sickle Cell Disease: SMYLS Multi-site Trial
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
October 2023 (Anticipated)
Primary Completion Date
July 2027 (Anticipated)
Study Completion Date
January 2028 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Medical University of South Carolina
Collaborators
National Institute of Nursing Research (NINR)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to find out whether a web-based intervention using a mobile app is helpful for teens and young adults with sickle cell disease (SCD) in learning how to care for and manage their symptoms.
Detailed Description
The purpose of this study is to test the effectiveness of and identify barriers and facilitators to the implementation of SMYLS, an mHealth intervention designed to facilitate self-management behaviors in adolescents and young adults (AYA) with sickle cell disease (SCD). Specifically, the investigators propose to determine the effect of the intervention on the primary outcome of self-management behaviors and the secondary outcomes of quality of life, transition readiness, healthcare utilization, and pain interference. In addition, the investigators will explore how patient activation moderates development of self-management behaviors and systemic, structural, and social variables that moderate relationships between patient activation, the primary outcome, and secondary outcomes.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sickle Cell Disease

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
272 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Intervention
Arm Type
Experimental
Arm Description
Study participants randomized to receive the intervention.
Arm Title
Control
Arm Type
Active Comparator
Arm Description
Study participants randomized to receive enhanced usual care (control).
Intervention Type
Behavioral
Intervention Name(s)
Voice Crisis Alert V2
Intervention Description
The mHealth self-management intervention consists of the following components: 1) condition-specific electronic educational materials; 2) pain/symptom monitoring and tracking; 3) health history information documentation; 4) medication tracking; 5) secure messaging with a provider; 6) functioning monitoring and tracking; and 7) transmission of health information (graphs with recorded pain and functioning histories) to a provider.
Intervention Type
Behavioral
Intervention Name(s)
Electronic educational materials
Intervention Description
The control arm will receive enhanced usual care, which will consist of usual educational materials distributed at the clinic plus a version of the intervention (Voice Crisis Alert V2) that only includes the electronic educational materials.
Primary Outcome Measure Information:
Title
Self-management behaviors
Description
Adolescent and young adult self-report using the Transition Readiness Assessment Questionnaire 5th version (TRAQ-5; 20 items). The instrument consists of 5 scales. Individual item scores range from 1 - 5. Scale scores are determined by calculating the average of the item scores within each scale. Higher scores indicate greater transition readiness and self-management behaviors.
Time Frame
baseline and 1, 3, 6, 9, 12 months
Secondary Outcome Measure Information:
Title
Engagement in intervention/control (categorical)
Description
Categorized into none, low, moderate and high. For intervention arm, categories are based on scope (number of components), duration (number of weeks), and frequency (number of times per week). For control arm, categories are based on duration and frequency as for intervention group parameters.
Time Frame
baseline and 1, 3, 6, 9, 12 months
Title
Engagement in intervention/control (continuous)
Description
Number of times the application is accessed (intervention = full application; control = educational component only).
Time Frame
Ongoing
Title
Health-related quality of life
Description
Adolescent and young adult self report using the Pediatric Quality of Life Inventory (PedsQL) with Sickle Cell Disease Module (43 items). Items are scaled from 0 (Never) to 4 (Almost always). Scores are reverse scored and linearly transformed to a 0 - 100 scale. Higher scores indicate better health-related quality of life.
Time Frame
baseline and 1, 3, 6, 9, and 12 months
Title
Number of attended SCD clinic visits
Description
Number of attended SCD clinic visits documented in the medical record
Time Frame
baseline and 1, 3, 6, 9, and 12 months
Title
Number of ED visits
Description
Number of ED visits documented in the medical record
Time Frame
baseline and 1, 3, 6, 9, and 12 months
Title
Number of hospitalizations
Description
Number of hospitalizations documented in the medical record
Time Frame
baseline and 1, 3, 6, 9, and 12 months
Title
Pain interference
Description
Adolescent and young adult self report using the Patient Reported Outcomes Measurement Inventory System (PROMIS) Pain Interference v2 Pediatric Short Form (8 items). Raw scores range from 0 - 32 with higher scores indicating greater pain interference.
Time Frame
baseline and 1, 3, 6, 9, and 12, months
Title
Transition readiness
Description
Adolescent and young adult self report using the Transition Intervention Program - Readiness for Transition (TIP-RFT; 22 items). Scores for each item range from 0 - 4, with a total possible summed score ranging from 0 - 88. Lower scores indicate higher transition readiness.
Time Frame
baseline and 1, 3, 6, 9, and 12 months
Other Pre-specified Outcome Measures:
Title
Patient activation
Description
Moderator variable; adolescent and young adult self-report using the Patient Activation Measure (PAM-13). Raw scores are transformed to a scale of 0 - 100 with 100 being the highest activation level.
Time Frame
baseline and 1, 3, 6, 9, and 12 months
Title
Neurocognitive/executive functioning
Description
Moderator variable; adolescent's parent/caregiver report using the Behavior Rating Inventory of Executive Function, 2nd ed. (BRIEF-2; 12 items). Raw scale scores are transformed to T scores. T scores from 60-64 are mildly elevated problems with executive functioning, T scores from 65-69 are considered potentially clinically elevated problems with executive functioning, and T scores at or above 70 are considered clinically elevated problems with executive functioning.
Time Frame
baseline, 9 months
Title
Social resources and conditions
Description
Moderator variable; based on residential address using the Child Opportunity Index (COI). 9-month measurement will assess change in address and change in COI. All United States neighborhoods are scored and ranked from lowest to highest opportunity. Five levels of opportunity are used (very low, low, moderate, high, very high) and scores range from 1 (lowest opportunity) to 100 (highest opportunity).
Time Frame
baseline, 9 months
Title
Depressive symptoms
Description
Moderator variable; adolescent and young adult self report using the Patient Reported Outcomes Measurement Information System (PROMIS) Depressive Symptoms v2 Pediatric Short Form (8 items). Raw scores range from 0 - 32 with higher scores indicating greater depressive symptoms.
Time Frame
baseline, 9 months
Title
Anxiety
Description
Moderator variable; adolescent and young adult self report using the Patient Reported Outcomes Measurement Information System (PROMIS) Anxiety v2 Pediatric Short Form (8 items). Raw scores range from 0 - 32 with higher scores indicating greater anxiety.
Time Frame
baseline, 9 months
Title
Fatigue
Description
Moderator variable; adolescent and young adult self report using the Patient Reported Outcomes Measurement Information System (PROMIS) Fatigue v2 Pediatric Short Form (10 items). Raw scores range from 0 - 40 with higher scores indicating greater fatigue.
Time Frame
baseline, 9 months
Title
Family functioning
Description
Moderator variable; parent/caregiver of adolescent report using the McMaster Family Functioning Assessment Device (12 items). Items response options range from 1 (strongly agree) to 4 (strongly disagree). All odd items are reverse scored. After reverse scoring, all items are summed. Lower total scores indicate higher levels of family functioning.
Time Frame
baseline, 9 months
Title
Health literacy
Description
Moderator variable; adolescent and young adult self report using the Newest Vital Sign (NVS; 6 items). Items are scored from 0 - 6 and summed. Total scores of 0 - 1 indicate a high likelihood of limited literacy, 2 - 3 a possibility of limited literacy, and 4 - 6 adequate literacy.
Time Frame
baseline, 9 months
Title
Perceived stigma
Description
Moderator variable; adolescent and young adult self report using the Child Stigma Scale (8 items). Each item is rated from from 0 (Never) to 4 (Very often). Higher scores indicate greater perceived stigma.
Time Frame
baseline, 9 months
Title
Sleep disturbance
Description
Moderator variable; adolescent and young adult self report using the Patient Reported Outcomes Measurement Information System (PROMIS) Sleep Disturbance v1 Pediatric Short Form (4 items). Raw scores range from 0 - 16 with higher scores indicating greater sleep disturbance.
Time Frame
baseline, 9 months
Title
Perceived discrimination
Description
Moderator variable; adolescent and young adult self report using the Discrimination subscale of the Interpersonal Processes of Care instrument (2 items). Response options range from 1 (Never) to 5 (Always). Total score is calculated as the mean of responses, with higher scores indicating higher frequency of discrimination.
Time Frame
baseline, 9 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
14 Years
Maximum Age & Unit of Time
21 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: documentation in the electronic health record of any type of SCD owns mobile device compatible with the intervention access to the internet Exclusion Criteria: Plans to relocate outside of study site area in the next 12 months Plans to transition to adult care in 12 months or less Parent/caregiver or provider report of neurocognitive impairment that precludes ability to use intervention and participate in study non-English speaking
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Shannon Phillips, PhD, RN
Phone
843-792-9379
Email
phillipss@musc.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Margie Prentice, MBA
Phone
843-792-4771
Email
prenticm@musc.edu
Facility Information:
Facility Name
Medical University of South Carolina
City
Charleston
State/Province
South Carolina
ZIP/Postal Code
29425
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

SMYLS Multi-site Trial

We'll reach out to this number within 24 hrs